Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ezio Zanon

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2007
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunctionFranca Bilora, Ezio Zanon, Alessandra Casonato, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2014
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand diseaseElena Pontara, Paolo Gresele, Maria Grazia Cattini, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 22, 2008
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedingsLuca Spiezia, Leonardo Meneghetti, Fabio Dalla Valle, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 17, 2009
Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single centerMaria Teresa Sartori, Silvia Imbergamo, Ezio Zanon, et al.
Hematology Reports|June 27, 2023
Managing Relevant Clinical Conditions of Hemophilia A/B PatientsMassimo Morfini, Jacopo Agnelli Giacchiello, Erminia Baldacci, et al.
Blood Transfusion = Trasfusione Del Sangue|July 24, 2020
Susoctocog-alfa (Obizur<sup>®</sup>) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experienceEzio Zanon, Samantha Pasca, Alessandra Borchiellini, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-AlfaCristina Novembrino, Ilaria Quaglia, Angelo Claudio Molinari, et al.
Blood Transfusion = Trasfusione Del Sangue|February 16, 2023
Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia CentersEzio Zanon, Raimondo De Cristofaro, Massimo Franchini, et al.
Research and Practice in Thrombosis and Haemostasis|June 3, 2026
Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovecFlora Peyvandi, Robert Klamroth, Johannes Oldenburg, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Personalized Prophylaxis with myPKFiT<sup>CE</sup>: A Real-World Cost-Effectiveness Analysis in Haemophilia A PatientsIppazio Cosimo Antonazzo, Paolo Angelo Cortesi, Ezio Zanon, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 4, 2007
Type IIb von Willebrand disease: role of qualitative defects in atherosclerosis and endothelial dysfunctionFranca Bilora, Ezio Zanon, Alessandra Casonato, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|January 15, 2014
Spontaneous hemarthrosis in combined Glanzmann thrombasthenia and type 2N von Willebrand diseaseElena Pontara, Paolo Gresele, Maria Grazia Cattini, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|October 22, 2008
Potential role of thrombelastography in the monitoring of acquired factor VIII inhibitor hemophilia A: report on a 78-year-old woman with life-threatening bleedingsLuca Spiezia, Leonardo Meneghetti, Fabio Dalla Valle, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|July 17, 2009
Effect of recombinant activated factor VII in critical bleeding: clinical experience of a single centerMaria Teresa Sartori, Silvia Imbergamo, Ezio Zanon, et al.
Hematology Reports|June 27, 2023
Managing Relevant Clinical Conditions of Hemophilia A/B PatientsMassimo Morfini, Jacopo Agnelli Giacchiello, Erminia Baldacci, et al.
Blood Transfusion = Trasfusione Del Sangue|July 24, 2020
Susoctocog-alfa (Obizur<sup>®</sup>) in the treatment of nine elderly patients with acquired haemophilia A: an Italian multicentre real world experienceEzio Zanon, Samantha Pasca, Alessandra Borchiellini, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Analytical Performance of Different Laboratory Methods for Measuring Susoctocog-AlfaCristina Novembrino, Ilaria Quaglia, Angelo Claudio Molinari, et al.
Blood Transfusion = Trasfusione Del Sangue|February 16, 2023
Bioequivalence of recombinant factor VIII products: a position paper from the Italian Association of Hemophilia CentersEzio Zanon, Raimondo De Cristofaro, Massimo Franchini, et al.
Research and Practice in Thrombosis and Haemostasis|June 3, 2026
Real-world provider experiences with hemophilia A gene therapy: administration of valoctocogene roxaparvovecFlora Peyvandi, Robert Klamroth, Johannes Oldenburg, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Personalized Prophylaxis with myPKFiT<sup>CE</sup>: A Real-World Cost-Effectiveness Analysis in Haemophilia A PatientsIppazio Cosimo Antonazzo, Paolo Angelo Cortesi, Ezio Zanon, et al.
Pageof 8